SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening
Author:
Publisher
Elsevier BV
Subject
Virology,Pharmacology
Reference49 articles.
1. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells;Bestle;Life Sci Alliance,2020
2. Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection;Bielarz;Brain Res.,2021
3. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia;Brann;Sci. Adv.,2020
4. Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2;Bullen;ALTEX,2020
5. Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: evaluation of 5676 Phase 1 Passed Structures;Chiu;J. Med. Virol.,2022
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of Fluorescence-Based Assays for Key Viral Proteins in the SARS-CoV-2 Infection Process and Lifecycle;International Journal of Molecular Sciences;2024-03-01
2. Management of Glioblastoma Multiforme During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: A Review of the Literature;World Neurosurgery;2023-10
3. Preclinical discovery and development of nirmatrelvir/ritonavir combinational therapy for the treatment of COVID-19 and the lessons learned from SARS-COV-2 variants;Expert Opinion on Drug Discovery;2023-08-23
4. Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface;International Journal of Molecular Sciences;2023-05-15
5. Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants;Antiviral Research;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3